Autres langues ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
65,36 ^USD	+0,63%		-0,18%	+18,53%

17/04	Un initié d'Ani Pharmaceuticals a vendu des actions d'une valeur de 1 500 589 $, selon un récent dépôt auprès de la SEC	MT
09/04	ANI Pharmaceuticals, Inc. annonce le lancement de Baclofen Oral Suspension	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	17/04
ANI Pharmaceuticals : Corporate Presentation - April 2024	17/04
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	03/04
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03/04
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals : Corporate Presentation - March 2024	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	08/03
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	06/03
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	06/03
Sector Update: Health Care Stocks Decline Late Afternoon	29/02
Sector Update: Health Care Stocks Retreat Thursday Afternoon	29/02
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	29/02
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
ANI: Q4 Earnings Snapshot	29/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Autres langues

Filtres